Skip to main content

Blood

Volume 481: debated on Tuesday 28 October 2008

To ask the Secretary of State for Health what plans the Advisory Committee on the Safety of Blood, Tissues and Organs has to undertake bacterial infection in blood trials as part of their comprehensive review of pathogen inactivation for blood products in 2009. (229595)

Information from NHS Blood and Transplant trials including published literature on pathogen inactivation will be discussed as part of the independent Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) review on options to reduce the risk of bacterial infection in blood. SaBTO does not commission research of this type. The Department in conjunction with the UK Blood Services have commissioned relevant research, trials and efficacy studies, which are due to be completed before any intervention is presented to SaBTO for their consideration and subsequently implemented.